Inactive Instrument

Polus BioPharm Inc.

A007630

KR7007630007

POLUS BioPharm Inc. announced that it has received KRW 20 billion in funding from KB Securities Co., Ltd., Investment Arm

March 08, 2018

On March 9, 2018, OLUS BioPharm Inc. (KOSE:A007630) closed the transaction. The company will change the conversion price to KRW 14,905 per share. The bonds are convertible into 1,341,831 common shares

Latest news about Polus BioPharm Inc.

Polus BioPharm Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-29	CI
Polus BioPharm Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Polus BioPharm Inc.(KOSE:A007630) dropped from S&P Global BMI Index	19-09-23	CI
POLUS BioPharm Inc. cancelled the acquisition of GTS Korea Co., Ltd.	19-05-20	CI
Polus BioPharm Inc. announced that it expects to receive KRW 29.999999966 billion in funding from Polus Holdings Co., Ltd	18-12-27	CI
Polus BioPharm Inc.(KOSE:A007630) added to S&P Global BMI Index	18-09-24	CI
Polus Inc. announced that it has received KRW 18 billion in funding from POLUS BioPharm Inc.	18-08-27	CI
Polus Inc. announced that it expects to receive KRW 18 billion in funding from POLUS BioPharm Inc.	18-08-26	CI
Polus BioPharm Inc. announced that it has received KRW 19 billion in funding from Union Savings Bank, Yuil Pe Investment Co.,Ltd., Mason Capital Corporation, Sky Savings Bank, Ltd and other investors	18-08-22	CI
POLUS BioPharm Inc. announced that it expects to receive KRW 18 billion in funding from Union Savings Bank, Youil PE Investment, Mason Capital Corporation, Sky Savings Bank, Ltd and another investor	18-08-19	CI
POLUS BioPharm Inc. announced that it has received KRW 1.80000415 billion in funding	18-05-28	CI
Polus Holdings Co., Ltd acquired additional stake in POLUS BioPharm Inc. from Akaglobal Co. Ltd., G & D Solution Co., Ltd. and PNA Bio Co., Ltd.	18-05-27	CI
Polus Inc. announced that it has received KRW 25 billion in funding from Polus BioPharm Inc.	18-05-24	CI
POLUS BioPharm Inc. agreed to acquire GTS Korea Co., Ltd. for KRW 3.6 billion.	18-05-20	CI
POLUS BioPharm Inc. announced that it expects to receive KRW 1.80000415 billion in funding	18-05-20	CI
POLUS BioPharm Inc. announced that it has received KRW 15 billion in funding from KB Securities Co., Ltd., Investment Arm	18-04-09	CI
Polus BioPharm Inc. announced that it expects to receive KRW 20 billion in funding from KB Securities Co., Ltd., Investment Arm	18-03-13	CI
POLUS BioPharm Inc. announced that it has received KRW 20 billion in funding from KB Securities Co., Ltd., Investment Arm	18-03-08	CI
Polus BioPharm Inc. announced that it expects to receive KRW 20 billion in funding from KB Securities Co., Ltd., Investment Arm	18-02-22	CI
Polus Inc. announced that it has received KRW 25 billion in funding from POLUS BioPharm Inc.	18-01-29	CI
Two individuals acquired 0.01% stake in Amnis Co., Ltd. from GND Solution for KRW 10 million.	18-01-23	CI
POLUS BioPharm Inc. announced that it has received KRW 72.50 billion in funding from NeoFidelity, Inc., Polus Holdings Co., Ltd	18-01-22	CI
Polus Inc. announced that it has received KRW 40 billion in funding from Amnis Co., Ltd.	18-01-18	CI
Polus, Inc. announced that it has received KRW 2 billion in funding from Polus BioPharm Inc.	18-01-09	CI
POLUS BioPharm Inc. announced that it has received KRW 5 billion in funding from Infinite Wisdom Co., Ltd.	18-01-02	CI

Chart Polus BioPharm Inc.

Duration

Period

More charts

Company Profile

POLUS BioPharm Inc., formerly AMNIS CO., LTD, is a Korea-based company mainly engaged in the manufacture and distribution of communications equipment. The Company operates its business through Communications Equipment Segment, Electronic Measuring Instrument Segment and Other Segment. Its Communications Equipment Segment mainly manufactures repeaters under the brand name of GSI. Its Electronic Measuring Instrument Segment mainly manufactures electronic measuring instruments under the brand name of Protek, and its Other Segment mainly provides communication related services. The Company distributes its products within domestic market and to overseas markets.

Sector

Communications & Networking

More about the company

Sector Network Equipment

	1st Jan change	Capi.
ACCTON TECHNOLOGY CORPORATION	+6.50%	9.58B
WILLFAR INFORMATION TECHNOLOGY CO., LTD.	+24.48%	2.42B
CICT MOBILE COMMUNICATION TECHNOLOGY CO., LTD.	-31.07%	2.34B
EXTREME NETWORKS, INC.	-26.47%	1.69B
ARCADYAN TECHNOLOGY CORPORATION	-3.52%	1.12B
SERCOMM CORPORATION	-11.52%	1.08B
FUJIAN STAR-NET COMMUNICATION CO., LTD.	-30.55%	1.02B
SHENZHEN PHOENIX TELECOM TECHNOLOGY CO.,LTD.	-30.22%	614M
ALPHA NETWORKS INC.	-3.84%	606M

Network Equipment